These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 28978205)

  • 41. Assessing key cost drivers associated with caring for chronic kidney disease patients.
    Damien P; Lanham HJ; Parthasarathy M; Shah NL
    BMC Health Serv Res; 2016 Dec; 16(1):690. PubMed ID: 28031020
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-Effectiveness Analysis of Patiromer in Combination with Renin-Angiotensin-Aldosterone System Inhibitors for Chronic Kidney Disease in Sweden.
    Widén J; Ivarsson M; Schalin L; Vrouchou P; Schwenkglenks M; Heimbürger O; Ademi Z; Sutherland CS
    Pharmacoeconomics; 2020 Jul; 38(7):747-764. PubMed ID: 32239480
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CKD stage at nephrology referral and factors influencing the risks of ESRD and death.
    Sud M; Tangri N; Levin A; Pintilie M; Levey AS; Naimark DM
    Am J Kidney Dis; 2014 Jun; 63(6):928-36. PubMed ID: 24485146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Short-term costs in patients with chronic kidney disease treated with dapagliflozin: a retrospective cohort study.
    Dwyer JP; Agiro A; Desai P; Cremisi H
    Expert Rev Pharmacoecon Outcomes Res; 2023; 23(9):1057-1066. PubMed ID: 37540162
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of Renal Disease on Patients with Hepatitis C: A Retrospective Analysis of Disease Burden, Clinical Outcomes, and Health Care Utilization and Cost.
    Solid CA; Peter SA; Natwick T; Guo H; Collins AJ; Arduino JM
    Nephron; 2017; 136(2):54-61. PubMed ID: 28214902
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of diagnosis-related groups on the cost of hospitalization for end-stage renal disease patients at Rhode Island Hospital from 1987 to 1990.
    Chazan JA; London MR; Pono L
    Am J Kidney Dis; 1992 Jun; 19(6):523-5. PubMed ID: 1595699
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A simulation model to estimate cost-offsets for a disease-management program for chronic kidney disease.
    Gandjour A; Tschulena U; Steppan S; Gatti E
    Expert Rev Pharmacoecon Outcomes Res; 2015 Apr; 15(2):341-7. PubMed ID: 25434825
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronic kidney disease care program improves quality of pre-end-stage renal disease care and reduces medical costs.
    Wei SY; Chang YY; Mau LW; Lin MY; Chiu HC; Tsai JC; Huang CJ; Chen HC; Hwang SJ
    Nephrology (Carlton); 2010 Feb; 15(1):108-15. PubMed ID: 20377778
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical and Economic Impact of Hyperkalemia in Patients with Chronic Kidney Disease and Heart Failure.
    Polson M; Lord TC; Kangethe A; Speicher L; Farnum C; Brenner M; Oestreicher N; Alvarez P
    J Manag Care Spec Pharm; 2017 Apr; 23(4-a Suppl):S2-S9. PubMed ID: 28485202
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence and economic burden of hyperkalemia in the United States Medicare population.
    Mu F; Betts KA; Woolley JM; Dua A; Wang Y; Zhong J; Wu EQ
    Curr Med Res Opin; 2020 Aug; 36(8):1333-1341. PubMed ID: 32459116
    [No Abstract]   [Full Text] [Related]  

  • 51. End-stage renal disease-financial costs and years of life lost in Panama: a cost-analysis study.
    Moreno Velásquez I; Tribaldos Causadias M; Valdés R; Gómez B; Motta J; Cuero C; Herrera-Ballesteros V
    BMJ Open; 2019 May; 9(5):e027229. PubMed ID: 31133590
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Economic burden of chronic kidney disease in Korea using national sample cohort.
    Kim SH; Jo MW; Go DS; Ryu DR; Park J
    J Nephrol; 2017 Dec; 30(6):787-793. PubMed ID: 28303461
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-dialysis dependent chronic kidney disease is associated with high total and out-of-pocket healthcare expenditures.
    Small C; Kramer HJ; Griffin KA; Vellanki K; Leehey DJ; Bansal VK; Markossian TW
    BMC Nephrol; 2017 Jan; 18(1):3. PubMed ID: 28056852
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Economic Burden of Chronic Kidney Disease and End-Stage Renal Disease.
    Wang V; Vilme H; Maciejewski ML; Boulware LE
    Semin Nephrol; 2016 Jul; 36(4):319-30. PubMed ID: 27475662
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The impact of chronic kidney disease on developed countries from a health economics perspective: A systematic scoping review.
    Elshahat S; Cockwell P; Maxwell AP; Griffin M; O'Brien T; O'Neill C
    PLoS One; 2020; 15(3):e0230512. PubMed ID: 32208435
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5.
    Karunaratne K; Stevens P; Irving J; Hobbs H; Kilbride H; Kingston R; Farmer C
    Nephrol Dial Transplant; 2013 Aug; 28(8):2107-16. PubMed ID: 23658247
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Managing comorbidities in chronic kidney disease reduces utilization and costs.
    Li Y; Barve K; Cockrell M; Agarwal A; Casebeer A; Dixon SW; Poonawalla I
    BMC Health Serv Res; 2023 Dec; 23(1):1418. PubMed ID: 38102650
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost of End-of-Life Inpatient Encounters in Patients with Chronic Kidney Disease in the United States: A Report from the DISCOVER CKD Retrospective Cohort.
    Pollock C; James G; Garcia Sanchez JJ; Arnold M; Carrero JJ; Lam CSP; Chen H; Nolan S; Pecoits-Filho R
    Adv Ther; 2022 Mar; 39(3):1432-1445. PubMed ID: 35112306
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mortality and treatment costs of hospitalized chronic kidney disease patients between the three major health insurance schemes in Thailand.
    Anutrakulchai S; Mairiang P; Pongskul C; Thepsuthammarat K; Chan-On C; Thinkhamrop B
    BMC Health Serv Res; 2016 Sep; 16(1):528. PubMed ID: 27686066
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of chronic kidney disease in patients undergoing percutaneous or surgical carotid artery revascularization: Insights of the healthcare cost and utilization Project's National Inpatient Sample.
    Lima FV; Yen TY; Butler J; Yang J; Xu J; Gruberg L
    Cardiovasc Revasc Med; 2016 Dec; 17(8):560-565. PubMed ID: 27988086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.